ReviewDigestive diseases and sciences2010
Gastrointestinal stromal tumors (GISTs): an updated experience.
Review in Digestive diseases and sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 27 citations in OpenAlex.
- The first case of primary extragastrointestinal stromal tumor of the kidney: a case description.Quantitative imaging in medicine and surgery · 2025Article
- Efficacy and safety of endoscopic subserosal dissection treatment for gastrointetinal submucosal tumors in the upper gastrointestinal tract.BMC surgery · 2024Article
- Gastrointestinal stromal tumor in the fourth portion of the duodenum does not express the CD117: A case report.Annals of medicine and surgery (2012) · 2022Article
- Primary gastrointestinal stromal tumor of the left hepatic lobe: a case report and a review of the literature.Journal of surgical case reports · 2021Article
- Life-threatening haematochezia in a man with two gastrointestinal stromal tumours.BMJ case reports · 2021Article
- Association Between the Nutritional Risk and the Survival Rate in Newly Diagnosed GIST Patients.Frontiers in nutrition · 2021Article
- Recent advances in the management of gastrointestinal stromal tumor.World journal of clinical cases · 2020Review
- Difference in Perfusion Parameters Between Gastric Cancer and Gastric Stromal Tumors: Evaluation With Oral Contrast Plus Contrast-Enhanced Ultrasonography.Frontiers in oncology · 2020Article
- Natural History of Exophytic Type Gastrointestinal Stromal Tumor: A Case Report.Yonago acta medica · 2019Article
- A report of three cases of exophytic gastrointestinal stromal tumor detected by transabdominal ultrasound.Journal of medical ultrasonics (2001) · 2016Article
- Primary gastrointestinal stromal tumor of the liver: report of a case.Surgery today · 2014Review
- Large cystic-based gastrointestinal stromal tumor: A case report.Oncology letters · 2014Article
- Pancreaticoduodenectomy versus local resection in the treatment of gastrointestinal stromal tumors of the duodenum.World journal of surgical oncology · 2013Article
- Gastrointestinal stromal tumor presenting with prominent calcification.World journal of gastroenterology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastrointestinal stromal tumors (GISTs) are relatively common mesenchymal tumors of the digestive tract characterized by c-KIT mutations. This is a comprehensive review of the current data of the literature on the various aspects of the diagnosis and treatment of these tumors.
methodsThe stomach is the most commonly involved site for these tumors in the digestive tract. Computed tomography and endoscopy can usually establish the diagnosis. The study of certain specific immunohistochemical markers may contribute to better characterization of these tumors.
resultsSurgical resection of GISTs has been the most effective therapy. In addition, targeted therapy with tyrosine kinase inhibitors may reduce the development of recurrence or decrease the disease progression in patients with metastatic disease.
conclusionsThe introduction of tyrosine kinase inhibitors has resulted in significant improvement in the overall prognosis of these patients. Furthermore, preoperative imatinib can decrease tumor volume and is associated with complete surgical resection in locally advanced primary GISTs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.